drugset
drugset / Trial / NCT05435170

Food Effect Study of Linerixibat Tablets in Healthy Adult Participants

NCT05435170 ↗

Phase 1 Completed 23 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

This study will evaluate the effect of food on the Pharmacokinetic (PK) and Pharmacodynamic (PD) parameters of linerixibat administered in fed and fasted states in heathy adult participants

Timeline

Start
2022-08-11
Primary completion
2022-10-10
Completion
2022-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Linerixibat Small molecule — —

Indications

No indication recorded.